Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-therapeutic acute leukemia.

G Auclerc, C Jacquillat, M F Auclerc

    Cancer
    |December 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Surveillance Bulletin 2007. Guidelines for clinical practice: management of patients with malignant epithelial tumors of the ovary. First line medical treatment].

    Bulletin du cancer·2007
    Same author

    Cancer in the elderly: are we ready?

    Current oncology reports·2000
    Same author

    [General treatment of metastatic prostatic cancer].

    Annales d'urologie·2000
    Same author

    Management of advanced prostate cancer.

    The oncologist·2000
    Same author

    Salpêtrière Hospital experience with biochemotherapy in metastatic melanoma.

    The cancer journal from Scientific American·1998
    Same author

    Docetaxel. A review of its role in breast cancer treatment.

    American journal of clinical oncology·1997
    Same journal

    Toward exercise as standard care for older cancer survivors.

    Cancer·2026
    Same journal

    Maintenance therapy in gynecologic malignancies: Current and future state.

    Cancer·2026
    Same journal

    Long-term outcomes of evolving treatment regimens in Ewing sarcoma survivors diagnosed 1970-1999: A report from the Childhood Cancer Survivor Study.

    Cancer·2026
    Same journal

    Large-scale osteosarcoma sequencing reveals age-associated genomic architectures.

    Cancer·2026
    Same journal

    EZH2 inhibitor tazemetostat voluntarily withdrawn from market.

    Cancer·2026
    Same journal

    Nivolumab and chemotherapy combination approved for previously untreated Hodgkin lymphoma.

    Cancer·2026
    See all related articles

    Therapeutic acute leukemia (AL) often follows chemotherapy or radiation, presenting with anemia and myelofibrosis. These leukemias have poor remission rates and short survival, prompting treatment modifications.

    Area of Science:

    • Hematology
    • Oncology
    • Medical Research

    Background:

    • Post-therapeutic acute leukemia (AL) is a serious complication following cancer treatments.
    • Characterized by preceding anemia, myelofibrosis, granulocytic predominance, low remission rates, and short survival.

    Purpose of the Study:

    • To report 35 cases of post-therapeutic AL.
    • To review the literature on this subject.
    • To discuss therapeutic modifications to mitigate risks.

    Main Methods:

    • Case series analysis of 35 patients.
    • Literature review on post-therapeutic AL.
    • Analysis of treatment protocols and outcomes.

    Main Results:

    • Identified key characteristics: preceding anemia (refractory), myelofibrosis, granulocytic AL, low remission, and short survival (months).

    Related Experiment Videos

  • AL developed after alkylating agent chemotherapy, radiotherapy, or combined treatments (e.g., Hodgkin's disease management).

    • Conclusions:

    • Post-therapeutic AL poses significant challenges due to poor prognosis.
    • Treatment strategies are evolving to reduce risks by modifying chemotherapy and radiotherapy regimens.